Published in Int J Womens Health on June 13, 2014
Expression and clinical significance of the HIF-1a/ET-2 signaling pathway during the development and treatment of polycystic ovary syndrome. J Mol Histol (2015) 0.79
Ovarian Drilling in PCOS: Is it Really Useful? Front Surg (2015) 0.79
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril (2004) 12.87
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med (2007) 7.31
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab (2000) 3.94
Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 3.86
Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr (2001) 3.81
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Long-term drug treatment for obesity: a systematic and clinical review. JAMA (2014) 3.69
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings? JAMA Intern Med (2014) 2.68
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
New obesity agents: lorcaserin and phentermine/topiramate. Ann Pharmacother (2013) 2.14
Novel clomiphene "stair-step" protocol reduces time to ovulation in women with polycystic ovarian syndrome. Am J Obstet Gynecol (2008) 2.11
Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med (1998) 2.04
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99
Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod (2008) 1.95
Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 1.90
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study. Fertil Steril (2011) 1.87
Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril (2008) 1.78
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab (2005) 1.76
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2012) 1.76
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord (2014) 1.64
A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update (2005) 1.63
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Efficacy of treatment for unexplained infertility. Fertil Steril (1998) 1.48
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod (2005) 1.43
The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab (2005) 1.37
Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia (2006) 1.33
Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes. Diabetologia (2003) 1.29
Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab (1998) 1.26
Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited. Fertil Steril (1984) 1.26
Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab (2012) 1.25
Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study. Fertil Steril (2011) 1.23
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.22
ACOG practice bulletin no. 105: bariatric surgery and pregnancy. Obstet Gynecol (2009) 1.20
A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol (2008) 1.18
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev (2012) 1.18
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) (1990) 1.09
Renaming PCOS--a two-state solution. J Clin Endocrinol Metab (2013) 1.08
Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update (2009) 1.08
Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet (2012) 1.08
The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod (2006) 1.08
Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.04
Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab (1999) 1.03
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril (2002) 1.02
High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod (2003) 1.01
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol (Oxf) (2008) 1.01
Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1987) 1.01
Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis (2011) 1.00
Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab (2006) 0.98
Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod (2003) 0.98
A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril (2012) 0.97
Multiple pregnancies following induction of ovulation. Fertil Steril (1981) 0.97
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod (2008) 0.96
Use of clomiphene citrate in women. Fertil Steril (2006) 0.95
Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril (2013) 0.94
Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril (1994) 0.92
A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod (2003) 0.90
Agents stimulating gonadal function in the human. Report of a WHO scientific group. World Health Organ Tech Rep Ser (1973) 0.90
Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev (2007) 0.89
Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab (2013) 0.89
Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril (2005) 0.89
Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol (Oxf) (2013) 0.89
Evaluation of ovarian adhesion formation after laparoscopic ovarian drilling by second-look minilaparoscopy. Fertil Steril (2007) 0.89
Letrozole for ovulation induction and controlled ovarian hyperstimulation. Curr Opin Obstet Gynecol (2010) 0.87
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults. Cochrane Database Syst Rev (2014) 0.86
Clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is .... J Clin Endocrinol Metab (2007) 0.85
Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome. BJOG (2005) 0.84
ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 34, February 2002. Management of infertility caused by ovulatory dysfunction. American College of Obstetricians and Gynecologists. Obstet Gynecol (2002) 0.83
Obesity drug therapy. Minerva Endocrinol (2013) 0.83
Defining the role of bariatric surgery in polycystic ovarian syndrome patients. World J Diabetes (2012) 0.81
Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial. Fertil Steril (2006) 0.80
Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation. Int J Fertil (1984) 0.80
[PCO syndrome--is it an indication for bariatric surgery?]. Zentralbl Chir (2008) 0.78
Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol Obstet Invest (2012) 0.78
A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. Am J Obstet Gynecol (2003) 0.78
The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS)--an extended critical analysis. Reprod Biomed Online (2007) 0.76
Assessing the risk of multiple gestation in gonadotropin intrauterine insemination cycles. Am J Obstet Gynecol (2002) 0.76
Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology. Womens Health (Lond Engl) (2012) 0.76
Novel clomiphene protocol in polycystic ovarian syndrome: Hurst et al. Am J Obstet Gynecol (2009) 0.75